TrialBlood cancer journal2018

Rapid, real time pathology review for ECOG/ACRIN 1412: a novel and successful paradigm for future lymphoma clinical trials in the precision medicine era.

Rebecca L King et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.